tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Latest News

PharmaCyte Biotech Discusses Upcoming Clinical Trial in Pancreatic Cancer with First Principle Investigator

Paper with Oncology and pills. Medical concept.

LAGUNA HILLS, Calif., Dec. 07, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box, released today the first article in a series of Q&A articles that will be conducted with some of the key team members of PharmaCyte’s planned clinical trial in locally advanced, inoperable pancreatic cancer (LAPC). PharmaCyte’s first Q&A article is with Dr. Matthias Löhr of the famed ...

Read More →
0

SPYR Targets Worldwide Audience for Pocket Starships as Asian Market Continues Solid Growth

SPYR Targets Worldwide Audience for Pocket Starships as Asian Market Continues Solid Growth

Written by Ι Stock Market Media — November 17, 2016

In 2016, the global games market grew to almost $100 billion according to Newzoo’s Global Games Market Report. In that report, China and the Asia-Pacific region account for almost half of the total revenue ($46.6 billion). SPYR, Inc. (OTCQB: SPYR) recognizes that getting its flagship MMO game Pocket Starships into that region and sharing in the revenue as that space continues to grow, should serve its shareholders well. SPYR recently added a video ...

Read More →
0

PharmaCyte Biotech Now Awaits U.S. FDA to Advance Pancreatic Cancer Therapy into Pivotal Clinical Trial

PharmaCyte Biotech Now Awaits U.S. FDA to Advance Pancreatic Cancer Therapy into Pivotal Clinical Trial

Written by Ι Stock Market Media — November 16, 2016

PharmaCyte Biotech (OTCQB: PMCB) has arrived at the door of U.S. FDA and awaits a pre-IND meeting with the agency. After years of surrounding its signature live-cell encapsulation technology, Cell-in-a-Box®, with some of the brightest minds in pancreatic cancer and fine-tuning its therapy and clinical trial design, the small biotech has reached the final test before it can begin its pivotal clinical trial in advanced pancreatic cancer.

PharmaCyte made two recent announcements that would ...

Read More →
0

SPYR Launches Worldwide Update of Pocket Starships with Hivespawn Expansion & Marketing Campaign

SPYR Launches Worldwide Update of Pocket Starships with Hivespawn Expansion & Marketing Campaign

Written by Ι Stock Market Media — September 8, 2016

This week SPYR, Inc. (OTCQB: SPYR) released a major content update (patch) for its flagship MMO game Pocket Starships. With this update, SPYR will launch its much-anticipated marketing and advertising campaign that should drive new gamers to SPYR’s real-time cross-platform game. This content update and the marketing campaign that will accompany it, mark the “official” worldwide launch of Pocket Starships.

As we have seen with the recent release of Pokémon Go, getting the word ...

Read More →
0

Pocket Starships Could Unite eSports and Mobile eSports Gamers

Pocket Starships Could Unite eSports and Mobile eSports Gamers

Written by Ι Stock Market Media — July 19, 2016

Worldwide the number of gamers who use mobile devices to play their favorite digital games is mind-boggling. So much so that some have called today’s gamers the “touchscreen generation.” SPYR, Inc. (OTCQB: SPYR) understands the trend is swinging heavily in favor of smartphones and tablets as the go-to devices that gamers are choosing, and SPYR also realizes that hardcore PC and console gamers aren’t ready to give up their choice for gaming either. ...

Read More →
0

As Diabetes Becomes Global Epidemic, PharmaCyte Biotech’s Insulin Producing Cells Receive 20 Years of Protection

As Diabetes Becomes Global Epidemic, PharmaCyte Biotech’s Insulin Producing Cells Receive 20 Years of Protection

Written by Ι Stock Market Media — July 19, 2016

Worldwide the number of people living with diabetes has reached 422 million, and if the current trend continues, over 700 million people are expected to be living with diabetes by 2025. Diabetes has clearly become a healthcare crisis on a global scale, and PharmaCyte Biotech (OTCQB: PMCB) recently received some good news in the form of patent protection that will help the company do its part in bringing a treatment to tens of ...

Read More →
0
Page 5 of 32 «...34567...»
ContactUs.com ContactUs.com